TDAM USA’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $12.2M | Sell |
205,861
-203,005
| -50% | -$10.1M | 0.75% | 32 |
|
|
2021
Q3 | $17.6M | Sell |
408,866
-2,108
| -0.5% | -$93.4K | 1.16% | 20 |
|
|
2021
Q2 | $17.6M | Sell |
410,974
-70,446
| -15% | -$2.74M | 1.09% | 21 |
|
|
2021
Q1 | $17.4M | Sell |
481,420
-2,789
| -0.6% | -$99K | 1.06% | 22 |
|
|
2020
Q4 | $17.8M | Sell |
484,209
-87,368
| -15% | -$3.2M | 1.12% | 22 |
|
|
2020
Q3 | $19.9M | Sell |
571,577
-47,160
| -8% | -$1.65M | 1.37% | 14 |
|
|
2020
Q2 | $19.2M | Sell |
618,737
-191,659
| -24% | -$6.51M | 1.39% | 14 |
|
|
2020
Q1 | $25.1M | Buy |
810,396
+90,842
| +13% | +$3.1M | 2.1% | 7 |
|
|
2019
Q4 | $26.7M | Sell |
719,554
-3,267
| -0.5% | -$116K | 1.74% | 7 |
|
|
2019
Q3 | $24.6M | Sell |
722,821
-14,027
| -2% | -$510K | 1.75% | 6 |
|
|
2019
Q2 | $30.3M | Buy |
736,848
+12,946
| +2% | +$514K | 2.12% | 5 |
|
|
2019
Q1 | $29.2M | Buy |
723,902
+145,674
| +25% | +$5.83M | 2.07% | 6 |
|
|
2018
Q4 | $23.9M | Buy |
578,228
+97,710
| +20% | +$4.06M | 1.74% | 6 |
|
|
2018
Q3 | $18.8M | Buy |
480,518
+8,009
| +2% | +$308K | 1.14% | 23 |
|
|
2018
Q2 | $16.3M | Sell |
472,509
-16,379
| -3% | -$560K | 1.03% | 28 |
|
|
2018
Q1 | $16.5M | Buy |
488,888
+40,358
| +9% | +$1.39M | 1% | 30 |
|
|
2017
Q4 | $15.4M | Buy |
448,530
+154,905
| +53% | +$5.28M | 0.88% | 33 |
|
|
2017
Q3 | $9.95M | Sell |
293,625
-20,814
| -7% | -$669K | 0.58% | 58 |
|
|
2017
Q2 | $10M | Buy |
314,439
+2,892
| +0.9% | +$91.2K | 0.52% | 69 |
|
|
2017
Q1 | $10.1M | Buy |
311,547
+21,878
| +8% | +$690K | 0.51% | 68 |
|
|
2016
Q4 | $8.93M | Sell |
289,669
-8,866
| -3% | -$271K | 0.47% | 72 |
|
|
2016
Q3 | $9.59M | Sell |
298,535
-15,725
| -5% | -$526K | 0.48% | 70 |
|
|
2016
Q2 | $10.5M | Sell |
314,260
-37,385
| -11% | -$1.19M | 0.52% | 66 |
|
|
2016
Q1 | $9.89M | Sell |
351,645
-21,574
| -6% | -$616K | 0.48% | 71 |
|
|
2015
Q4 | $11.4M | Sell |
373,219
-14,803
| -4% | -$466K | 0.55% | 65 |
|
|
2015
Q3 | $11.6M | Sell |
388,022
-19,973
| -5% | -$640K | 0.59% | 57 |
|
|
2015
Q2 | $13M | Sell |
407,995
-57,422
| -12% | -$1.87M | 0.59% | 59 |
|
|
2015
Q1 | $15.4M | Sell |
465,417
-12,212
| -3% | -$388K | 0.62% | 58 |
|
|
2014
Q4 | $14.1M | Sell |
477,629
-23,518
| -5% | -$674K | 0.6% | 63 |
|
|
2014
Q3 | $14.1M | Sell |
501,147
-72,683
| -13% | -$2.04M | 0.61% | 59 |
|
|
2014
Q2 | $16.2M | Sell |
573,830
-16,892
| -3% | -$482K | 0.68% | 55 |
|
|
2014
Q1 | $18M | Sell |
590,722
-140,963
| -19% | -$4.2M | 0.78% | 43 |
|
|
2013
Q4 | $21.3M | Sell |
731,685
-783,969
| -52% | -$22.8M | 0.92% | 36 |
|
|
2013
Q3 | $41.3M | Sell |
1,515,654
-67,070
| -4% | -$1.82M | 1.95% | 7 |
|
|
2013
Q2 | $40.9M | Buy |
+1,582,724
| New | +$43.7M | 1.87% | 11 |
|
Other funds holding PFE
TDAM USA's PFE Position: Q4 2021 in Review
TDAM USA reduced its Pfizer (PFE) stake by 50% in Q4 2021, selling an estimated $10.1M and leaving 205,861 shares worth $12.2M. The position accounts for 0.75% of the portfolio, ranked #32.
TDAM USA first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. The position peaked at $41.3M in Q3 2013. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- TDAM USA held 205,861 shares of Pfizer worth $12.2M as of Q4 2021.
- TDAM USA sold 203,005 Pfizer shares in Q4 2021, an estimated $10.1M.
- Pfizer made up 0.75% of TDAM USA's portfolio in Q4 2021, its #32 holding.
- TDAM USA first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- TDAM USA's Pfizer position peaked at $41.3M in Q3 2013.
- 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.